Table 5.
Biochemical quantifications of glutathione, myeloperoxidase, and alkaline phosphatase in the colon of animals submitted to the chronic colitis model.
| Glutathione (GSH) (nmol/g) | |||
|---|---|---|---|
| GSH 1st week | GSH 2nd week | GSH 3rd week | |
| Non-colitic | 1,727.88 ± 95.34* | 1,134.20 ± 79.27 | 1,726.73 ± 34.92∗# |
| TNBS control | 1,323.49 ± 43.15 | 1,353.74 ± 77.53 | 1,374.42 ± 77.55# |
| EC 10 | 1,662.56 ± 99.92* | 1,236.37 ± 45.62 | 1,673.06 ± 82.37∗# |
| EC 50 | 1,529.50 ± 87.26 | 1,150.68 ± 52.38 | 1,658.92 ± 110.49 |
| Sulfasalazine | 1,555.76 ± 141.52 | 1,269.79 ± 57.53 | 1,562.79 ± 110.64# |
| Not relapsed TNBS | — | — | 1,914.64 ± 63.62* |
|
| |||
| Myeloperoxidase (MPO) (U/g) | |||
| MPO 1st week | MPO 2nd week | MPO 3rd week | |
|
| |||
| Non-colitic | 64.56 ± 19.05* | 101.65 ± 6.63* | 71.69 ± 5.64∗# |
| TNBS control | 377.52 ± 85.14 | 219.49 ± 25.09 | 634.42 ± 149.44# |
| EC 10 | 386.31 ± 76.80 | 247.64 ± 34.71 | 401.91 ± 70.28 |
| EC 50 | 463.36 ± 98.97 | 211.67 ± 51.93 | 504.98 ± 144.73 |
| Sulfasalazine | 383.79 ± 81.39 | 179.12 ± 26.34 | 450.46 ± 73.96# |
| Not relapsed TNBS | — | — | 225.23 ± 46.09* |
|
| |||
| Alkaline phosphatase (ALP) (mU/mg of protein) | |||
| ALP 1st week | ALP 2nd week | ALP 3rd week | |
|
| |||
| Non-colitic | 20.93 ± 2.21* | 28.18 ± 1.56* | 17.56 ± 1.39* |
| TNBS control | 46.94 ± 2.62 | 40.02 ± 3.63 | 27.39 ± 3.76 |
| EC 10 | 54.04 ± 6.67 | 34.96 ± 1.56 | 27.23 ± 2.10 |
| EC 50 | 49.89 ± 7.95 | 48.16 ± 9.97 | 30.31 ± 1.20 |
| Sulfasalazine | 55.92 ± 7.85 | 39.40 ± 5.07 | 38.38 ± 4.96# |
| Not relapsed TNBS | — | — | 24.25 ± 2.71 |
Results expressed as mean ± E.P.M. ANOVA-Dunnet comparing to the checks of each group. *P < 0.05 comparing to TNBS control, # P < 0.05 comparing to not relapsed TNBS control. n = 4–7. EC 10 and 50: Epicatechin, dose 10 and 50 mg/kg.